Glutathione and Colorectal Tumor Sensitivity to ZD2767 Therapy
Author Information
Author(s): Monks N R, Calvete J A, Curtin N J, Blakey D C, East S J, Newell D R
Primary Institution: Cancer Research Unit, University of Newcastle upon Tyne
Hypothesis
The study investigates whether cellular glutathione levels affect the sensitivity of colorectal tumor cell lines to ZD2767 antibody-directed enzyme prodrug therapy.
Conclusion
Depleting glutathione did not significantly enhance the effectiveness of the ZD2767 therapy in colorectal tumor cell lines.
Supporting Evidence
- There was no significant relationship between glutathione concentration and sensitivity to the therapy.
- Depleting glutathione only modestly increased the therapy's activity.
Takeaway
The amount of a certain chemical in cancer cells didn't help the treatment work better, even when we tried to lower it.
Methodology
The study evaluated the relationship between glutathione levels and the effectiveness of ZD2767P therapy in colorectal tumor cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website